Invasive pneumococcal disease in children >5 years of age in rural Mozambique

Tropical Medicine and International Health

Volumn 11, Issue 9, 2006, Pages 1422-1431

  Roca, A ^a,b   Sigauque B ^b,c   Quintó, Ll ^a,b   Mandomando, I ^b,c   Valles X ^a,b   Espasa, M ^a,b   Abacassamo, F ^b,d   Sacarlal, J ^b,d   MacEte, E ^b,e   Nhacolo, A ^b   Levine, M ^f   Alonso, P ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministérioda Saúde   (Mozambique)

^c INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^d EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^e School of Science ^*  (Mozambique)

^f UNIVERSITY OF MARYLAND   (United States)

Author keywords

Africa; Clinical presentation; Incidence; Invasive pneumococcal disease; Pneumococcus

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; CHILD HEALTH; DISEASE INCIDENCE; HEALTH RISK; MANAGEMENT PRACTICE; RURAL AREA; SEASONAL VARIATION;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; FATALITY; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; PENICILLIN RESISTANCE; PNEUMONIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; RURAL AREA; SEASONAL VARIATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

AGE DISTRIBUTION; ANTI-INFECTIVE AGENTS; CHILD, PRESCHOOL; CHLORAMPHENICOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; MOZAMBIQUE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMONIA; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; RURAL HEALTH; SEX DISTRIBUTION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

AFRICA; MOZAMBIQUE; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 33747881703     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2006.01697.x     Document Type: Article

References (38)

1. Abacassamo F, Enosse S, Aponte JJ et al. (2004) Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. Tropical Medicine and International Health 9, 200-208.
2. Alonso PL, Smith T, Schellenberg JR et al. (1994) Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344, 1175-1181.
3. Alonso PL, Saúte F, Aponte JJ et al. (2002) Manhiça DSS, Mozambique. In: In Population Health in Developing Countries (eds OA Sankoh, P Ngom, P Nyarko, E Mwageni & K Kahn) Ottawa: International Development Research Center (IDRC), 2002: 89-195.
4. Alonso PL, Sacarlal J, Aponte JJ et al. (2004) Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364, 1411-1420.
5. Barreto A, Mac Arthur J, Saúte F et al. (2004) Impacto Demográfico do HIV/SIDA em Moçambique - Actualização. UNICEF and DFID. Instituto Nacional de Estatística (INE); Ministerio de Saúde (MISAU); Ministerio do Plano e Finanzas (MPF); Centro de estudos da população da Universidade Eduardo Mondlane (CEP); UEM- Consello Nacional de combate ao HIV/SIDA (CNCS); Facultade de Medicina-UEM, Moçambique, pp. 1-89.
6. Berkley JA, Lowe BS, Mwangi I et al. (2005) Bacteremia among children admitted to a rural hospital in Kenya. The New England Journal of Medicine 352, 39-47.
7. Campbell JD, Kotloff KL, Sow SO et al. (2004) Invasive pneumococcal infections among hospitalized children in Bamako, Mali. The Pediatric Infectious Disease Journal 23, 642-649.
8. Chintu C, Bhat GJ, Walker AS et al. (2004) Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 364, 1865-1871.
9. Cutts FT, Zaman SM, Enwere G et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365, 1139-1146.
10. Dowell SF, Whitney CG, Wright C, Rose CE Jr & Schuchat A (2003) Seasonal patterns of invasive pneumococcal disease. Emerging Infectious Diseases 9, 573-579.
11. Eskola J, Takala AK, Kela E et al. (1992) Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 268, 3323-3327.
12. Feikin DR, Davis M, Nwanyanwu OC et al. (2003) Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children. The Pediatric Infectious Disease Journal 22, 564-567.
13. Greenwood B (1999) The epidemiology of pneumococcal infection in children in the developing world. Philosophical Transactions of the Royal Society London Series B Biological Sciences 354, 777-785.
14. Inostroza J, Vinet AM, Retamal G et al. (2001) Influence of patient age on Streptococcus pneumoniae serotypes causing invasive disease. Clinical and Diagnostic Laboratory Immunology 8, 556-559.
15. Klugman KP (2004) Vaccination: a novel approach to reduce antibiotic resistance. Clinical Infectious Diseases 39, 649-651.
16. Klugman KP, Madhi SA, Huebner RE et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. The New England Journal of Medicine 349, 1341-1348.
17. Liebowitz LD, Slabbert M & Huisamen A (2003) National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. Journal of Clinical Pathology 56, 344-347.
18. Loscertales MP, Roca A, Ventura PJ et al. (2002) Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. The Pediatric Infectious Disease Journal 21, 148-155.
19. Madhi SA, Petersen K, Madhi A, Wasas A & Klugman KP (2000) Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. The Pediatric Infectious Disease Journal 19, 1141-1147.
20. NCCLS (2000) Approved standards. In: NCCLS, Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th Edn. NCCLS, Wayne, PA, p 20.
21. Obaro SK (2000) Prospects for pneumococcal vaccination in African children. Acta Tropica 75, 141-153.
22. O'Dempsey TJ, Mcardle TF, Lloyd-Evans N et al. (1996a) Pneumococcal disease among children in a rural area of west Africa. The Pediatric Infectious Disease Journal 15, 431-437.
23. O'Dempsey TJ, Mcardle TF, Morris J et al. (1996b) A study of risk factors for pneumococcal disease among children in a rural area of west Africa. International Journal of Epidemiology 25, 885-893.
24. Paul J (1997) Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 12 December 1996. HIV and pneumococcal infection in Africa. Microbiological aspects. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 632-637.
25. Peter G & Klein JO (1996) Pneumococcal vaccine. Pediatrics in Review 17, 335-341.
26. Robertson SE, Roca A, Alonso P et al. (2004) Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bulletin of the World Health Organization 82, 914-922.
27. Robinson KA, Baughman W, Rothrock G et al. (2001) Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 285, 1729-1735.
28. Saute F, Aponte J, Almeda J et al. (2005) Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhiça district. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 655-660.
29. Shann F (1993) Nutritional indices: Z, centile, or percent? Lancet 341, 526-527.
30. StataCorp (2003) Stata Statistical Software: Release 8.0. Stata Corporation, College Station, TX.
31. Tomasz A (1997) Antibiotic resistance in Streptococcus pneumoniae. Clinical Infectious Diseases 24 (Suppl. 1), S85-S88.
32. Ulloa-Gutierrez R, Avila-Aguero ML, Herrera ML, Herrera JF & Arguedas A (2003) Invasive pneumococcal disease in Costa Rican children: a seven year survey. The Pediatric Infectious Disease Journal 22, 1069-1074.
33. Usen S, Adegbola R, Mulholland K et al. (1998) Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia. The Pediatric Infectious Disease Journal 17, 23-28.
34. Vallès FX, Flannery B, Roca A et al. (2006) Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus Pneumoniae among children in rural Mozambique. Tropical Medicine and International Health 2 (3): 358-366.
35. Weber MW, Milligan P, Sanneh M et al. (2002) An epidemiological study of RSV infection in the Gambia. Bulletin of the World Health Organization 80, 562-568.
36. Whitney CG, Farley MM, Hadler J et al. (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. The New England Journal of Medicine 348, 1737-1746.
37. WHO (1999) Pneumococcal vaccines: World Health Organization position paper. Canada Communicable Disease Report 25, 150-151.
38. WHO Young Infants Study Group (1999) Clinical prediction of serious bacterial infections in young infants in developing countries. The Pediatric Infectious Disease Journal 18, S23-S31.